A Phase I Study to Investigate the Absorption, Distribution, Metabolism and Excretion of [14C]-S-600918 Following Oral Dose Administration in Healthy Adult Male Subjects
Latest Information Update: 13 Oct 2022
At a glance
- Drugs Sivopixant (Primary)
- Indications Cough; Neuropathic pain; Sleep apnoea syndrome
- Focus Pharmacokinetics
- Sponsors Shionogi
- 20 Dec 2021 New trial record